FDA’s Awkward Transition Continues

US FDA’s apolitical leadership team is highly unusual – but is it a strength or a weakness in a new Administration? Acting Commissioner Janet Woodcock has been running the agency for nearly six months and there are no signs of the status quo changing any time soon.

IS THE PROGRESS BAR STUCK ON THE BIDEN ADMINISTRATION TRANSITION AT FDA? • Source: Illustration

As Janet Woodcock approaches six months on the job as acting Commissioner of the US Food & Drug Administration, the agency continues in an unprecedented leadership position amid the transition to a new Presidency.

On the one hand, Woodcock is (or was?) President Joe Biden’s first choice to run the agency, and – despite...

More from US FDA

More from Agency Leadership